The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Neurol.
Sec. Stroke
Volume 16 - 2025 |
doi: 10.3389/fneur.2025.1510235
Predicting Prognosis Using Stroke-Heart Indicator: Brain Natriuretic Peptide in Patients with Aneurysmal Subarachnoid Hemorrhage
Provisionally accepted- 1 Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing Municipality, China
- 2 Peking Union Medical College Hospital (CAMS), Beijing, Beijing Municipality, China
Objective: This study aims to explore the correlation between brain natriuretic peptide (BNP) levels and prognosis in patients suffering from aneurysmal subarachnoid hemorrhage (aSAH).Methods: This retrospective study included patients diagnosed with aneurysmal subarachnoid hemorrhage (aSAH) at Beijing Tiantan Hospital between January 2015 and September 2021. Plasma BNP levels were measured upon admission and log-transformed to reduce skewness. Elevated BNP was defined as lgBNP ≥ 1.79 (equivalent to BNP ≥62 pg/mL). The primary outcome was poor prognosis, defined as a modified Rankin Scale (mRS) score ≥3 at 90 days. Univariable and multivariable logistic regression analyses were conducted to examine the association between BNP levels and prognosis. Additionally, we assessed the potential impact of incorporating BNP into a predictive model for poor prognosis Results: The statistical analysis encompassed a total of 932 patients. Among them, 171 individuals experienced unfavorable prognosis (mRS ≥3) during follow-up, and 444 patients had elevated BNP levels, defined as lgBNP ≥ 1.79. After accounting for confounding factors, elevated BNP levels remained a significant independent risk factor of a poor prognosis (p=0.047, OR= 1.49, 95%CI= 1.01-2.20). Nevertheless, BNP's predictive value alone might not warrant its inclusion in a prognostic model. Conclusion: Elevated BNP levels independently forecast unfavorable prognosis in patients with aSAH, even though the cutoff value is lower than the cardiology standards. Continuous monitoring and personalized hospitalization plans can be vital for these patients.
Keywords: stroke heart disease, ASAH, bnp, Retrospective Studies, Risk factors
Received: 12 Oct 2024; Accepted: 10 Jan 2025.
Copyright: © 2025 Xue, LIN, Liu, Song, Li, Chen, Yang, Han, Jia, Chen, Wang and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jionghao Xue, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, Beijing Municipality, China
Minghao Liu, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, Beijing Municipality, China
Wenxiong Song, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, Beijing Municipality, China
Heze Han, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, Beijing Municipality, China
Yitong Jia, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, Beijing Municipality, China
XiaoLin Chen, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, Beijing Municipality, China
Rong Wang, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, Beijing Municipality, China
Yuanli Zhao, Peking Union Medical College Hospital (CAMS), Beijing, 100730, Beijing Municipality, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.